Skip to content

Alveolar Ridge Preservation in Post-Extraction Sockets Using Advanced Platelet-Rich Fibrin versus Concentrated Growth Factors: A Randomized, Controlled Clinical Trial.

Alveolar Ridge Preservation in Post-Extraction Sockets Using Advanced Platelet-Rich Fibrin versus Concentrated Growth Factors: A Randomized, Controlled Clinical Trial.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20251028003
Enrollment
60
Registered
2025-10-28
Start date
2025-01-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

impacted lower third molars Alveolar Ridge Preservation

Interventions

Fresh venous blood from patients was used to collect autologous A PRF. They were divided into two clean 10 ml tubes without adding any anticoagulants, and they were centrifuged immediately using A PRF
temperature in the chamber21
speed: 150 *10rpm. Each A PRF clot was taken out of the tube after centrifugation and spited from the red element phase using scissors, Fresh venous blood from patients was used to collect autologous
and speed: 230*10rpm. Each CGF clot was taken out of the tube after centrifugation and split from the red element phase using scissor.,Natural blood clot was used from Fresh venous blood as placebo.
Experimental Procedure/Surgery,Experimental Procedure/Surgery,Placebo Comparator No treatment
Advanced Platelet-Rich Fibrin,Concentrated Growth Factors,Natural blood clot

Sponsors

University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years. 2. Patients with completely or partially impacted lower third molars. 3. Patients who require surgical extraction. 4. Patients had no evidence of pericoronitis or periapical pathology. 5. Patients who are cooperative and able to attend follow-up visits. 6. Patients have no history of systemic disease or the use of systemic medications.

Exclusion criteria

Exclusion criteria: 1. pregnant or lactating women. 2. patients receiving non steroidal antiinflammatory drugs, anticoagulant therapy, or long term steroid treatment. 3. patients with systemic conditions that compromise immunity, such as diabetes mellitus, hypothyroidism, HIV infection, AIDS, severe liver disease, malnutrition, adrenal insufficiency, or Cushing's syndrome. 4. Smokers. 5. patients with pericoronitis.

Design outcomes

Primary

MeasureTime frame
Socket height and width within 24 hours after extraction, then after 3 months Cone-beam computed tomography (CBCT)

Secondary

MeasureTime frame
Pain at first, third, and seventh days postoperatively Using Visual Analog Scale which ranges between 0 (no pain) and 10 (worst pain), facial swelling first, third, and seventh days postoperatively using flexible ruler to measure two distance; attachment of the ear lobe, and the corner of the mouth; and lateral canthus of the eye and mandibular angle

Countries

Yemen

Contacts

Public ContactHeba Hail

University of Science and Technology

hebaseef94@gmail.com733662697

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026